AKT1 and cancer: The level of phospho-AKT, which was found to be increased in HGF/EGF-stimulated cells after treatment with cetuximab alone reverted back to basal untreated values in the presence of MetHer1 in five cancer cell lines of different tissue origins (Figures 5a and b).